The international peer-reviewed journal known as Oncotarget has reported on cutting-edge cancer research for over a decade now. Their main focus is researching the effects that cancer has on one’s hope, anxiety, overall quality of life, and satisfaction. They have found that there is a direct correlation between the patient’s mindset and their ability to fight cancer. The more hopeful a patient is, the higher percentage chance they have in winning the battle against cancer. Because of this, Oncotarget researches the latest cancer management programs and then rates them depending on how therapeutic they are, as well as, how well they target the cancer. Visit Oncotarget’s profile page at facebook.com.
Dr. Carmelo Nucero sat down with Oncotarget to discuss cutting-edge research that is likely to give hope to thousands of people who suffer papillary thyroid carcinoma. The cancer papillary thyroid carcinoma has been one to squash hope for years. It carries a reputation with it for becoming resistant to vemurafenib which is the most common drug used to treat it. The reason this resistance occurs is that the BRAF gene, which is targeted by vemurafenib, begins to build up an immunity and fights the drug off. This has led to many patients receiving the news that the cancer has left remission and is now both inoperable and incurable.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
Dr. Carmelo Nucero, however, was able to find a way to get the body to stop attacking vemurafenib so that the patient could receive treatment for their papillary thyroid carcinoma. The way to he was able to accomplish this was by mixing vemurafenib with the advanced breast cancer medication palbociclib. This causes the immune system to fight palbociclib while leaving vemurafenib to deal with the papillary thyroid carcinoma.
When the two drugs are mixed together, they become a miracle serum that truly increases the longevity of the patient. Dr. Carmelo Nucero reports that when used in concert they promote healthy cell regeneration and cancer cell elimination.
To hear more about this wonderful research as well as other things coming into the field of cancer research download and listen to Oncotarget’s podcast off of iTunes today. Watch this video on Youtube.